FDA Commissioner Stephen Hahn was quoted at a recent White House Coronavirus Task Force press briefing emphasizing that in the “sea of new treatments” we need to connect “the right drug to the right patient at the right dosage at the right time. As an example, we may have the right drug, but it may not be in the appropriate dosage form right now, and that may do more harm than good. Those are the things that that’s our job to look at.”

In our latest Insight from the Experts podcast, NFP's Head of Innovation Mark Rieder sits down with Joe Spinelli, chief marketing officer of MedTek21, to discuss how risk management using genomics can bring personalized medicine to every patient.